Publications by authors named "Franz Dotzer"

Claim this Profile
[
[Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial].
Adnan Kastrati, Julinda Mehilli, Josef Dirschinger, Franz Dotzer, Helmut Schuhlen

Vestn Rentgenol Radiol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial.
Stefanie Schulz, Julinda Mehilli, Gjin Ndrepepa, Franz Dotzer, Michael Dommasch

Clin Res Cardiol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial.
Stefanie Schulz, K Anette Birkmeier, Gjin Ndrepepa, Werner Moshage, Franz Dotzer

Clin Res Cardiol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.
Julinda Mehilli, Adnan Kastrati, Stefanie Schulz, Stefan Früngel, Stephan G Nekolla, Franz Dotzer

Circulation· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment.
Raisuke Iijima, Gjin Ndrepepa, Julinda Mehilli, Franz-Josef Neumann, Stefanie Schulz, Franz Dotzer

Clin Res Cardiol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.
Gjin Ndrepepa, Adnan Kastrati, Julinda Mehilli, Franz-Josef Neumann, Jurriën ten Berg, Franz Dotzer

Eur Heart J· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.
Julinda Mehilli, Gjin Ndrepepa, Adnan Kastrati, Franz-Josef Neumann, Jurriën ten Berg, Franz Dotzer

Am Heart J· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions.
Gjin Ndrepepa, Adnan Kastrati, Julinda Mehilli, Franz-Josef Neumann, Jurriën ten Berg, Franz Dotzer

Circulation· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel.
Helmut Schühlen, Adnan Kastrati, Julinda Mehilli, Jörg Hausleiter, Josef Dirschinger, Franz Dotzer

Am Heart J· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.
Adnan Kastrati, Julinda Mehilli, Franz-Josef Neumann, Franz Dotzer, Jurriën ten Berg

JAMA· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel.
Albert Schömig, Claus Schmitt, Alban Dibra, Julinda Mehilli, Christian Volmer, Franz Dotzer

Eur Heart J· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
Julinda Mehilli, Adnan Kastrati, Helmut Schühlen, Alban Dibra, Franz Dotzer

Circulation· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization.
David E Kandzari, Peter B Berger, Adnan Kastrati, Steven R Steinhubl, Julinda Mehilli, Franz Dotzer

J Am Coll Cardiol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial.
Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Michael Vogeser, Dietlind Zohlnhöfer, Franz Dotzer

Circulation· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
Adnan Kastrati, Julinda Mehilli, Klaus Schlotterbeck, Franz Dotzer, Josef Dirschinger

JAMA· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.
Adnan Kastrati, Julinda Mehilli, Helmut Schühlen, Josef Dirschinger, Franz Dotzer

N Engl J Med· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial.
Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Helmut Schühlen, Jürgen Pache, Franz Dotzer

Am Heart J· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial.
Jürgen Pache, Adnan Kastrati, Julinda Mehilli, Helmut Schühlen, Franz Dotzer

J Am Coll Cardiol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries.
Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Helmut Schühlen, Jürgen Pache, Franz Dotzer

J Am Coll Cardiol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of stent placement versus balloon angioplasty in small coronary arteries with long narrowings (the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries [ISAR-SMART] Trial).
Jörg Hausleiter, Adnan Kastrati, Julinda Mehilli, Franz Dotzer, Helmut Schühlen

Am J Cardiol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus.
Julinda Mehilli, Adnan Kastrati, Josef Dirschinger, Franz Dotzer, Jürgen Pache

Am J Med· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis